Skip to main content
Cocrystal Pharma, Inc. (FRA:8CC)
Germany flag Germany · Delayed Price · Currency is EUR
0.860
-0.005 (-0.58%)
Last updated: Dec 5, 2025, 8:02 AM CET

Cocrystal Pharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
-----2.01
Upgrade
Revenue Growth (YoY)
------69.32%
Upgrade
Cost of Revenue
5.4712.5415.1712.398.796.03
Upgrade
Gross Profit
-5.47-12.54-15.17-12.39-8.79-4.02
Upgrade
Selling, General & Admin
4.35.345.995.755.435.57
Upgrade
Operating Expenses
4.35.345.995.755.435.57
Upgrade
Operating Income
-9.77-17.88-21.16-18.14-14.22-9.59
Upgrade
Interest Expense
----0-0-0.01
Upgrade
Interest & Investment Income
0.140.540.64---
Upgrade
Currency Exchange Gain (Loss)
-0.05-0.16-0.07-0.02-0.01-
Upgrade
Other Non Operating Income (Expenses)
---0.010.05-0.05
Upgrade
EBT Excluding Unusual Items
-9.67-17.5-20.58-18.15-14.19-9.65
Upgrade
Impairment of Goodwill
----19.09--
Upgrade
Legal Settlements
--2.6-1.6--
Upgrade
Pretax Income
-9.67-17.5-17.98-38.84-14.19-9.65
Upgrade
Net Income
-9.67-17.5-17.98-38.84-14.19-9.65
Upgrade
Net Income to Common
-9.67-17.5-17.98-38.84-14.19-9.65
Upgrade
Shares Outstanding (Basic)
101010875
Upgrade
Shares Outstanding (Diluted)
101010875
Upgrade
Shares Change (YoY)
1.91%5.42%18.52%10.58%60.04%73.32%
Upgrade
EPS (Basic)
-0.93-1.72-1.86-4.77-1.93-2.10
Upgrade
EPS (Diluted)
-0.93-1.72-1.86-4.77-1.93-2.10
Upgrade
Free Cash Flow
-9.63-16.49-14.78-21.51-12.77-10.07
Upgrade
Free Cash Flow Per Share
-0.93-1.62-1.53-2.64-1.73-2.19
Upgrade
Gross Margin
------199.60%
Upgrade
Operating Margin
------475.97%
Upgrade
Profit Margin
------479.05%
Upgrade
Free Cash Flow Margin
------500.00%
Upgrade
EBITDA
-9.68-17.75-20.97-17.95-14.03-9.43
Upgrade
D&A For EBITDA
0.090.130.190.190.190.16
Upgrade
EBIT
-9.77-17.88-21.16-18.14-14.22-9.59
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.